These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19233290)

  • 21. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.
    Robert R; Dolezal O; Waddington L; Hattarki MK; Cappai R; Masters CL; Hudson PJ; Wark KL
    Protein Eng Des Sel; 2009 Mar; 22(3):199-208. PubMed ID: 18927231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combining intracellular selection with protein-fragment complementation to derive Aβ interacting peptides.
    Acerra N; Kad NM; Mason JM
    Protein Eng Des Sel; 2013 Jul; 26(7):463-70. PubMed ID: 23708321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation and characterization of a highly soluble Aβ
    LeVatte MA; Lipfert M; Ladner-Keay C; Wishart DS
    Protein Expr Purif; 2019 Dec; 164():105480. PubMed ID: 31425755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generic hydrophobic residues are sufficient to promote aggregation of the Alzheimer's Abeta42 peptide.
    Kim W; Hecht MH
    Proc Natl Acad Sci U S A; 2006 Oct; 103(43):15824-9. PubMed ID: 17038501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression, purification and identification of Abeta fusion protein with enhanced solubility].
    Zhu R; Zheng CD; Wang F
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar; 30(3):447-50. PubMed ID: 20335106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of amyloid-beta aggregation inhibitors using an engineered assay for intracellular protein folding and solubility.
    Lee LL; Ha H; Chang YT; DeLisa MP
    Protein Sci; 2009 Feb; 18(2):277-86. PubMed ID: 19177561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of an Aβ-antibody fragment on Aβ aggregation and astrocytic uptake are modulated by apolipoprotein E and J mimetic peptides.
    Montoliu-Gaya L; Mulder SD; Veerhuis R; Villegas S
    PLoS One; 2017; 12(11):e0188191. PubMed ID: 29155887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production and Use of Recombinant Aβ for Aggregation Studies.
    O'Malley TT; Linse S; Walsh DM
    Methods Mol Biol; 2018; 1777():307-320. PubMed ID: 29744844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of Alzheimer's amyloid-beta aggregation in-vitro by carbenoxolone: Insight into mechanism of action.
    Sharma S; Nehru B; Saini A
    Neurochem Int; 2017 Sep; 108():481-493. PubMed ID: 28652220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and Purification of Intrinsically Disordered Aβ Peptide and Setup of Reproducible Aggregation Kinetics Experiment.
    Linse S
    Methods Mol Biol; 2020; 2141():731-754. PubMed ID: 32696387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of the amyloid-beta peptide N terminus in Saccharomyces cerevisiae expressing human Alzheimer's amyloid-beta precursor protein.
    Greenfield JP; Xu H; Greengard P; Gandy S; Seeger M
    J Biol Chem; 1999 Nov; 274(48):33843-6. PubMed ID: 10567340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of N-Terminal Cysteine Aβ
    Zhang S; Guaglianone G; Morris MA; Yoo S; Howitz WJ; Xing L; Zheng JG; Jusuf H; Huizar G; Lin J; Kreutzer AG; Nowick JS
    Biochemistry; 2021 Apr; 60(15):1191-1200. PubMed ID: 33793198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant amyloid beta-peptide production by coexpression with an affibody ligand.
    Macao B; Hoyer W; Sandberg A; Brorsson AC; Dobson CM; Härd T
    BMC Biotechnol; 2008 Oct; 8():82. PubMed ID: 18973685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Humoral immune response to fibrillar beta-amyloid peptide.
    Miller DL; Currie JR; Mehta PD; Potempska A; Hwang YW; Wegiel J
    Biochemistry; 2003 Oct; 42(40):11682-92. PubMed ID: 14529278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Copper enhances amyloid-beta peptide neurotoxicity and non beta-aggregation: a series of experiments conducted upon copper-bound and copper-free amyloid-beta peptide.
    Dai X; Sun Y; Gao Z; Jiang Z
    J Mol Neurosci; 2010 May; 41(1):66-73. PubMed ID: 19685013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression, purification, and characterization of recombinant human beta-amyloid42 peptide in Escherichia coli.
    Zhang L; Yu H; Song C; Lin X; Chen B; Tan C; Cao G; Wang Z
    Protein Expr Purif; 2009 Mar; 64(1):55-62. PubMed ID: 18996484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of amino-acid substitutions on Alzheimer's amyloid-beta peptide-glycosaminoglycan interactions.
    McLaurin J; Fraser PE
    Eur J Biochem; 2000 Nov; 267(21):6353-61. PubMed ID: 11029577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and purification of two different antimicrobial peptides, PR-39 and Protegrin-1 in Escherichia coli.
    Fan F; Wu Y; Liu J
    Protein Expr Purif; 2010 Oct; 73(2):147-51. PubMed ID: 20573563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of amyloid-beta glycine 33 in oligomerization, toxicity, and neuronal plasticity.
    Harmeier A; Wozny C; Rost BR; Munter LM; Hua H; Georgiev O; Beyermann M; Hildebrand PW; Weise C; Schaffner W; Schmitz D; Multhaup G
    J Neurosci; 2009 Jun; 29(23):7582-90. PubMed ID: 19515926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A routine method for cloning, expressing and purifying Aβ(1-42) for structural NMR studies.
    Weber DK; Sani MA; Gehman JD
    Amino Acids; 2014 Oct; 46(10):2415-26. PubMed ID: 25027618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.